UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 47

Sortiert nach

An Endogenous Capsaicin-like Substance with High Potency at Recombinant and Native Vanilloid VR1 Receptors

Proceedings of the National Academy of Sciences - PNAS, 2002-06, Vol.99 (12), p.8400-8405

2002

Link zum Volltext

Verfügbarkeit prüfen

INfluenza Vaccine Indication During therapy with Immune checkpoint inhibitors: a multicenter prospective observational study (INVIDIa-2)

Journal for immunotherapy of cancer, 2021-05, Vol.9 (5), p.e002619

2021

Link zum Volltext

Verfügbarkeit prüfen

Atezolizumab in a CoHort of pretreated, advanced, non-small cell lung cancer patients with rare HistologiCal SubtypEs (CHANCE trial)

Therapeutic advances in medical oncology, 2020, Vol.12, p.1758835920915983-1758835920915983

2020

Link zum Volltext

Verfügbarkeit prüfen

Symptomatic COVID-19 in advanced-cancer patients treated with immune-checkpoint inhibitors: prospective analysis from a multicentre observational trial by FICOG

Therapeutic advances in medical oncology, 2020, Vol.12, p.1758835920968463

2020

Link zum Volltext

Verfügbarkeit prüfen

The vanilloid receptor (VR1)‐mediated effects of anandamide are potently enhanced by the cAMP‐dependent protein kinase

Journal of neurochemistry, 2001-06, Vol.77 (6), p.1660-1663

2001

Link zum Volltext

Verfügbarkeit prüfen

Anandamide Excites Central Terminals of Dorsal Root Ganglion Neurons via Vanilloid Receptor-1 Activation

The Journal of neuroscience, 2001-02, Vol.21 (4), p.1104-1109

2001

Link zum Volltext

Verfügbarkeit prüfen

Role of peripheral N-methyl-D-aspartate (NMDA) receptors in visceral nociception in rats

Gastroenterology (New York, N.Y. 1943), 2001-06, Vol.120 (7), p.1737-1748

2001

Link zum Volltext

Verfügbarkeit prüfen

Neurogenic responses mediated by vanilloid receptor‐1 (TRPV1) are blocked by the high affinity antagonist, iodo‐resiniferatoxin

British journal of pharmacology, 2003-03, Vol.138 (5), p.977-985

2003

Link zum Volltext

Verfügbarkeit prüfen

Expression and Function of Proteinase-activated Receptor 2 in Human Bronchial Smooth Muscle

American journal of respiratory and critical care medicine, 2001-10, Vol.164 (7), p.1276-1281

2001

Link zum Volltext

Verfügbarkeit prüfen

Phase II, Open-label, Single-arm, Multicenter Study to Assess the Activity and Safety of Alectinib as Neoadjuvant Treatment in Surgically Resectable Stage III ALK-positive NSCLC: ALNEO Trial

Clinical lung cancer, 2021-09, Vol.22 (5), p.473-477

2021

Link zum Volltext

Verfügbarkeit prüfen

Presence and bronchomotor activity of protease-activated receptor-2 in guinea pig airways

American journal of respiratory and critical care medicine, 2000-05, Vol.161 (5), p.1672-1680

2000

Link zum Volltext

Verfügbarkeit prüfen

Oncology clinical trials in the time of COVID-19: how a pandemic can revolutionize patients’ care

Future oncology (London, England), 2020-07, Vol.16 (20), p.1413-1415

2020

Link zum Volltext

Verfügbarkeit prüfen

NK1 receptor stimulation causes contraction and inositol phosphate increase in medium-size human isolated bronchi

American journal of respiratory and critical care medicine, 2001-04, Vol.163 (5), p.1206-1211

2001

Link zum Volltext

Verfügbarkeit prüfen

Clinical impact of COVID-19 in a single-center cohort of a prospective study in cancer patients receiving immunotherapy

Immunotherapy, 2020-10, Vol.12 (15), p.1139-1148

2020

Link zum Volltext

Verfügbarkeit prüfen

Abstract 2914: Molecular characterization with single-cell resolution of CTCs and FFPE specimens from the same lung adenocarcinoma patients reveals the extent of intra-tumor heterogeneity

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.2914-2914

2017

Link zum Volltext

Verfügbarkeit prüfen

Abstract 2253: Digital sorting and single-cell genomic profile comparison of lung adenocarcinoma CTCs between EpCAM and size-based enrichment methods

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.2253-2253

2016

Link zum Volltext

Verfügbarkeit prüfen

Atezolizumab in a C o H ort of pretreated, advanced, non-small cell lung cancer patients with rare HistologiCal Subtyp E s (CHANCE trial)

Therapeutic advances in medical oncology, 2020-01, Vol.12, p.175883592091598

2020

Link zum Volltext

Verfügbarkeit prüfen

Impact of influenza vaccination on survival of patients with advanced cancer receiving immune checkpoint inhibitors (INVIDIa-2): final results of the multicentre, prospective, observational studyResearch in context

EClinicalMedicine, 2023-07, Vol.61, p.102044

2023

Link zum Volltext

Verfügbarkeit prüfen

Impact of influenza vaccination on survival of patients with advanced cancer receiving immune checkpoint inhibitors (INVIDIa-2): final results of the multicentre, prospective, observational study

EClinicalMedicine, 2023-07, Vol.61, p.102044-102044, Article 102044

2023

Link zum Volltext

Verfügbarkeit prüfen

Atezolizumab in a oort of pretreated, advanced, non-small cell lung cancer patients with rare HistologiCal Subtyps (CHANCE trial)

Therapeutic advances in medical oncology, 2020-07, Vol.12

2020

Link zum Volltext

Verfügbarkeit prüfen

An evaluation of pharmacologic costs of complete liver resections in unselected advanced colorectal cancer patients

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.e17551-e17551

2013

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 47

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(47)
Mit Volltextzugriff
(42)

Publikationsform

Artikel
(47)

Sprache

Englisch
(47)
Japanisch
(7)

Erscheinungsjahr

n.n

Thema

Science & Technology
(30)
Life Sciences & Biomedicine
(28)
Humans
(19)
Male
(14)
Biological And Medical Sciences
(10)
Animals
(9)
Female
(9)
Oncology
(8)
In Vitro Techniques
(7)
Pharmacology & Pharmacy
(7)
Aged
(5)
Cancer
(5)
Dose-Response Relationship, Drug
(5)
Fundamental And Applied Biological Sciences. Psychology
(5)
General & Internal Medicine
(5)
Guinea Pigs
(5)
Immunohistochemistry
(5)
Immunotherapy
(5)
Medical Sciences
(5)
Muscle Contraction - Drug Effects
(5)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

An Endogenous Capsaicin-like Substance with High Potency at Recombinant and Native Vanilloid VR1 Receptors

Randomized, open-label, phase II, biomarker study of immune-mediated mechanism of action of neoadjuvant subcutaneous trastuzumab in patients with locally advanced, inflammatory, or early HER2-positive breast cancer—Immun-HER trial (GOIRC-01-2016)

INfluenza Vaccine Indication During therapy with Immune checkpoint inhibitors: a multicenter prospective observational study (INVIDIa-2)

Atezolizumab in a CoHort of pretreated, advanced, non-small cell lung cancer patients with rare HistologiCal SubtypEs (CHANCE trial)

Symptomatic COVID-19 in advanced-cancer patients treated with immune-checkpoint inhibitors: prospective analysis from a multicentre observational trial by FICOG

The vanilloid receptor (VR1)‐mediated effects of anandamide are potently enhanced by the cAMP‐dependent protein kinase

Anandamide Excites Central Terminals of Dorsal Root Ganglion Neurons via Vanilloid Receptor-1 Activation

Role of peripheral N-methyl-D-aspartate (NMDA) receptors in visceral nociception in rats

Neurogenic responses mediated by vanilloid receptor‐1 (TRPV1) are blocked by the high affinity antagonist, iodo‐resiniferatoxin

Expression and Function of Proteinase-activated Receptor 2 in Human Bronchial Smooth Muscle

Phase II, Open-label, Single-arm, Multicenter Study to Assess the Activity and Safety of Alectinib as Neoadjuvant Treatment in Surgically Resectable Stage III ALK-positive NSCLC: ALNEO Trial

Presence and bronchomotor activity of protease-activated receptor-2 in guinea pig airways

Oncology clinical trials in the time of COVID-19: how a pandemic can revolutionize patients’ care

A phase II, open-label, single-arm trial of carboplatin plus etoposide with bevacizumab and atezolizumab in patients with extended-stage small-cell lung cancer (CeLEBrATE study): background, design and rationale

NK1 receptor stimulation causes contraction and inositol phosphate increase in medium-size human isolated bronchi

Clinical impact of COVID-19 in a single-center cohort of a prospective study in cancer patients receiving immunotherapy

Abstract 2914: Molecular characterization with single-cell resolution of CTCs and FFPE specimens from the same lung adenocarcinoma patients reveals the extent of intra-tumor heterogeneity

Phase II study of eribulin in combination with gemcitabine for the treatment of patients with locally advanced or metastatic triple negative breast cancer: ERIGE trial on behalf of the Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC)

Abstract 2253: Digital sorting and single-cell genomic profile comparison of lung adenocarcinoma CTCs between EpCAM and size-based enrichment methods

Atezolizumab in a C o H ort of pretreated, advanced, non-small cell lung cancer patients with rare HistologiCal Subtyp E s (CHANCE trial)

Impact of influenza vaccination on survival of patients with advanced cancer receiving immune checkpoint inhibitors (INVIDIa-2): final results of the multicentre, prospective, observational studyResearch in context

Impact of influenza vaccination on survival of patients with advanced cancer receiving immune checkpoint inhibitors (INVIDIa-2): final results of the multicentre, prospective, observational study

Atezolizumab in a oort of pretreated, advanced, non-small cell lung cancer patients with rare HistologiCal Subtyps (CHANCE trial)

An evaluation of pharmacologic costs of complete liver resections in unselected advanced colorectal cancer patients

Suchergebnisse filtern